Skip to main content

Table 1 Patients’ characteristics

From: Combination of FDG-PET and FMISO-PET as a treatment strategy for patients undergoing early-stage NSCLC stereotactic radiotherapy

CharacteristicNo. 
Age
 Median (range)83 (56–89) 
Gender
 Male1959.4%
 Female1340.6%
Histology
 Adenocarcinoma2475.0%
 Squamous cell carcinoma721.9%
 Non-small cell carcinoma13.1%
Morphology
 Solid/part solid2681.3%
 GGO618.8%
Stage  
 I2371.9%
 II928.1%
Prescription dose:
 40 Gy/4 fr (PTV D95)2371.9%
 48 Gy/4 fr (isocenter)928.1%
Prognosis
 Non-recurrent2371.9%
 Recurrent928.1%
  1. PTV planning target volume